Creative Planning Increases Stock Position in Cardlytics, Inc. (NASDAQ:CDLX)

Creative Planning grew its holdings in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 35.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 29,537 shares of the company’s stock after purchasing an additional 7,721 shares during the period. Creative Planning owned approximately 0.06% of Cardlytics worth $95,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CDLX. Canton Hathaway LLC boosted its stake in shares of Cardlytics by 95.7% in the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock valued at $37,000 after buying an additional 2,200 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of Cardlytics during the 2nd quarter worth $107,000. Banco Santander S.A. purchased a new position in shares of Cardlytics in the 1st quarter valued at about $199,000. SG Americas Securities LLC acquired a new stake in shares of Cardlytics in the third quarter valued at about $45,000. Finally, Quest Partners LLC boosted its holdings in Cardlytics by 160.4% during the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after buying an additional 11,061 shares in the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.

Cardlytics Price Performance

Cardlytics stock opened at $4.23 on Wednesday. The stock has a market capitalization of $214.97 million, a P/E ratio of -0.69 and a beta of 1.61. Cardlytics, Inc. has a 12-month low of $2.89 and a 12-month high of $20.52. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.77. The firm’s 50-day moving average is $3.72 and its two-hundred day moving average is $6.52.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18. The firm had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. Cardlytics’s revenue was down 15.1% compared to the same quarter last year. During the same quarter last year, the business earned ($0.26) earnings per share. Equities analysts predict that Cardlytics, Inc. will post -1.72 earnings per share for the current year.

Insider Activity at Cardlytics

In related news, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the completion of the sale, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders sold 43,573 shares of company stock worth $151,612. 4.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CDLX. Evercore ISI initiated coverage on Cardlytics in a research note on Friday, October 11th. They set an “in-line” rating and a $4.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Northland Capmk cut Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Bank of America downgraded Cardlytics from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $4.00 to $3.50 in a research note on Thursday, August 15th. Finally, Northland Securities cut shares of Cardlytics from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $7.00 to $5.00 in a research note on Friday, August 16th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.